{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:33:44Z","timestamp":1793374424434,"version":"4.5.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82460559"],"award-info":[{"award-number":["82460559"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gansu Province Health Industry Science and Technology Innovation Major Projects","award":["No. GSWSKY2024-06"],"award-info":[{"award-number":["No. GSWSKY2024-06"]}]},{"name":"The Cuiying Science and Technology Innovation Project of Lanzhou University Second Hospital","award":["Nos. CY2024-MS-B18"],"award-info":[{"award-number":["Nos. CY2024-MS-B18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03989-7","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:45:08Z","timestamp":1758739508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Historical evolution and current research status of lymph node staging in gastric cancer: a review"],"prefix":"10.1186","volume":"23","author":[{"given":"Yinghong","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangzu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"3989_CR1","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1245\/ASO.2003.03.520","volume":"10","author":"D Nitti","year":"2003","unstructured":"Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol. 2003;10:1077\u201385. https:\/\/doi.org\/10.1245\/ASO.2003.03.520.","journal-title":"Ann Surg Oncol"},{"key":"3989_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-022-01331-8","volume":"26","author":"Japanese Gastric Cancer Association","year":"2022","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer. 2022;26:1\u201325. https:\/\/doi.org\/10.1007\/s10120-022-01331-8.","journal-title":"Gastric Cancer"},{"key":"3989_CR3","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. 8th ed. New York: Springer; 2017.","edition":"8"},{"key":"3989_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-82982-6","volume-title":"TNM classification of malignant tumours","year":"1987","unstructured":"Hermanek P, Sobin LH, editors. TNM classification of malignant tumours. Berlin: Springer; 1987. https:\/\/doi.org\/10.1007\/978-3-642-82982-6."},{"key":"3989_CR5","volume-title":"AJCC cancer staging manual","author":"ID Fleming","year":"1997","unstructured":"Fleming ID, Cooper JS, Henderson DE. AJCC cancer staging manual. Volume 304, 5th ed. New York: Springer; 1997.","edition":"5"},{"key":"3989_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/(sici)1097-0142(19980215)82:4621::aid-cncr23.3.co;2-2","volume":"82","author":"JD Roder","year":"1998","unstructured":"German Gastric Cancer Study Group, Roder JD, B\u00f6ttcher K, et al. Classification of regional lymph node metastasis from gastric carcinoma. Cancer. 1998;82:621\u201331. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19980215)82:4621::aid-cncr23.3.co;2-2.","journal-title":"Cancer"},{"key":"3989_CR7","doi-asserted-by":"publisher","unstructured":"American Joint Committee on Cancer. AJCC Cancer Staging Manual. New York: Springer; 2002. https:\/\/doi.org\/10.1007\/978-1-4757-3656-4","DOI":"10.1007\/978-1-4757-3656-4"},{"key":"3989_CR8","volume-title":"Internationa union against cancer (UICC) TNM classification of malignant tumors","author":"LH Sobin","year":"2010","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C. Internationa union against cancer (UICC) TNM classification of malignant tumors. 7th ed. New York: Wiley-Liss; 2010.","edition":"7"},{"key":"3989_CR9","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1245\/s10434-010-0939-x","volume":"17","author":"J Deng","year":"2010","unstructured":"Deng J, Liang H, Sun D, et al. Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China. Ann Surg Oncol. 2010;17:1259\u201366. https:\/\/doi.org\/10.1245\/s10434-010-0939-x.","journal-title":"Ann Surg Oncol"},{"key":"3989_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11605-011-1707-3","volume":"16","author":"LJ McGhan","year":"2012","unstructured":"McGhan LJ, Pockaj BA, Gray RJ, et al. Validation of the updated 7th edition AJCC TNM staging criteria for gastric adenocarcinoma. J Gastrointest Surg. 2012;16:53\u201361. https:\/\/doi.org\/10.1007\/s11605-011-1707-3.","journal-title":"J Gastrointest Surg"},{"key":"3989_CR11","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1245\/s10434-010-1424-2","volume":"18","author":"W Wang","year":"2010","unstructured":"Wang W, Sun X, Li C, et al. Comparison of the 6th and 7th editions of the UICC TNM staging system for gastric cancer: results of a Chinese Single-Institution study of 1,503 patients. Ann Surg Oncol. 2010;18:1060\u20137. https:\/\/doi.org\/10.1245\/s10434-010-1424-2.","journal-title":"Ann Surg Oncol"},{"key":"3989_CR12","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1007\/s00268-011-1275-4","volume":"35","author":"W Fang","year":"2011","unstructured":"Fang W, Huang K, Chen J, et al. Comparison of the survival difference between AJCC 6th and 7th editions for gastric cancer patients. World J Surg. 2011;35:2723\u20139. https:\/\/doi.org\/10.1007\/s00268-011-1275-4.","journal-title":"World J Surg"},{"key":"3989_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10120-016-0601-9","volume":"20","author":"T Sano","year":"2016","unstructured":"Sano T, Coit DG, Kim HH, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: international gastric cancer association staging project. Gastric Cancer. 2016;20:217\u201325. https:\/\/doi.org\/10.1007\/s10120-016-0601-9.","journal-title":"Gastric Cancer"},{"key":"3989_CR14","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ijsu.2014.06.014","volume":"12","author":"K-H Jun","year":"2014","unstructured":"Jun K-H, Lee J-S, Kim J-H, et al. The rationality of N3 classification in the 7th edition of the international union against cancer TNM staging system for gastric adenocarcinomas: A case-control study. Int J Surg. 2014;12:893\u20136. https:\/\/doi.org\/10.1016\/j.ijsu.2014.06.014.","journal-title":"Int J Surg"},{"key":"3989_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/PL00011681","volume":"1","author":"Japanese Gastric Cancer Association","year":"1998","unstructured":"Japanese Gastric Cancer Association. Japanese classification of gastric Carcinoma \u2013 2nd english Edition \u2013. Gastric Cancer. 1998;1:10\u201324. https:\/\/doi.org\/10.1007\/PL00011681.","journal-title":"Gastric Cancer"},{"issue":"10","key":"3989_CR16","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3760\/cma.j.issn.1671-0274.2018.10.007","volume":"21","author":"LY Sun","year":"2018","unstructured":"Sun LY. Development trend of assessment system in gastric cancer based on evolution of staging criteria. Chin J Gastrointest Surg. 2018;21(10):1113\u201320. https:\/\/doi.org\/10.3760\/cma.j.issn.1671-0274.2018.10.007.","journal-title":"Chin J Gastrointest Surg"},{"key":"3989_CR17","volume-title":"Surgical oncology of gastric cancer","author":"WH Zhan","year":"2014","unstructured":"Zhan WH. Surgical oncology of gastric cancer. Beijing: People\u2019s Health Publishing House; 2014."},{"key":"3989_CR18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00595-021-02395-2","volume":"52","author":"T Nakamura","year":"2021","unstructured":"Nakamura T, Hojo Y, Kumamoto T, et al. History of the lymph node numbering system in the Japanese classification of gastric carcinoma since 1962. Surg Today. 2021;52:1515\u201323. https:\/\/doi.org\/10.1007\/s00595-021-02395-2.","journal-title":"Surg Today"},{"key":"3989_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","volume":"14","author":"Japanese Gastric Cancer Association","year":"2011","unstructured":"Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd english edition. Gastric Cancer. 2011;14:101\u201312. https:\/\/doi.org\/10.1007\/s10120-011-0041-5.","journal-title":"Gastric Cancer"},{"key":"3989_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-020-01042-y","volume":"24","author":"Japanese Gastric Cancer Association","year":"2020","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2020;24:1\u201321. https:\/\/doi.org\/10.1007\/s10120-020-01042-y.","journal-title":"Gastric Cancer"},{"key":"3989_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10120-016-0632-2","volume":"20","author":"A Mizuno","year":"2016","unstructured":"Mizuno A, Shinohara H, Haruta S, et al. Lymphadenectomy along the infrapyloric artery May be dispensable when performing pylorus-preserving gastrectomy for early middle-third gastric cancer. Gastric Cancer. 2016;20:543\u20137. https:\/\/doi.org\/10.1007\/s10120-016-0632-2.","journal-title":"Gastric Cancer"},{"key":"3989_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/bjs.1800790404","volume":"79","author":"JA Akoh","year":"1992","unstructured":"Akoh JA, Macintyre IMC. Improving survival in gastric cancer: review of 5-year survival rates in english Language publications from 1970. Br J Surg. 1992;79:293\u20139. https:\/\/doi.org\/10.1002\/bjs.1800790404.","journal-title":"Br J Surg"},{"key":"3989_CR23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0039-6109(16)45688-4","volume":"72","author":"KE Behrns","year":"1992","unstructured":"Behrns KE, Dalton RR, Van Heerden JA, et al. Extended lymph node dissection for gastric cancerd: is it of value?? Surg Clin North Am. 1992;72:433\u201343. https:\/\/doi.org\/10.1016\/S0039-6109(16)45688-4.","journal-title":"Surg Clin North Am"},{"key":"3989_CR24","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(96)90144-0","volume":"347","author":"A Cuschieri","year":"1996","unstructured":"Cuschieri A, Joypaul V, Fayers P, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet. 1996;347:995\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(96)90144-0.","journal-title":"Lancet"},{"key":"3989_CR25","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1056\/NEJM199903253401202","volume":"340","author":"JJ Bonenkamp","year":"1999","unstructured":"Bonenkamp JJ, Hermans J, Sasako M, et al. Extended Lymph-Node dissection for gastric cancer. N Engl J Med. 1999;340:908\u201314. https:\/\/doi.org\/10.1056\/NEJM199903253401202.","journal-title":"N Engl J Med"},{"key":"3989_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1470-2045(10)70070-X","volume":"11","author":"I Songun","year":"2010","unstructured":"Songun I, Putter H, Kranenbarg EM-K, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439\u201349. https:\/\/doi.org\/10.1016\/S1470-2045(10)70070-X.","journal-title":"Lancet Oncol"},{"key":"3989_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0304-3835(89)90159-6","volume":"45","author":"K Maruyama","year":"1989","unstructured":"Maruyama K. The general rule of JRSGC and treatment results by the rule. Cancer Lett. 1989;45:155. https:\/\/doi.org\/10.1016\/0304-3835(89)90159-6.","journal-title":"Cancer Lett"},{"key":"3989_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00000658-199307000-00008","volume":"218","author":"Y Nio","year":"1993","unstructured":"Nio Y, Tsubono M, Kawabata K, et al. Comparison of survival curves of gastric cancer patients after surgery according to the UICC stage classification and the general rules for gastric cancer study by the Japanese research society for gastric cancer. Ann Surg. 1993;218:47\u201353. https:\/\/doi.org\/10.1097\/00000658-199307000-00008.","journal-title":"Ann Surg"},{"key":"3989_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-94-009-2167-2_12","volume-title":"New trends in gastric cancer","author":"K Maruyama","year":"1990","unstructured":"Maruyama K, Kinoshita T, Sasako M, et al. The general rule of the Japanese research society for gastric cancer and treatment results by the rule. In: Reed PI, Carboni M, Johnston BJ, et al. editors. New trends in gastric cancer. Dordrecht: Springer Netherlands; 1990. pp. 119\u201324. https:\/\/doi.org\/10.1007\/978-94-009-2167-2_12."},{"key":"3989_CR30","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/S0140-6736(96)12249-2","volume":"349","author":"RJ Schlemper","year":"1997","unstructured":"Schlemper RJ, Itabashi M, Kato Y, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet. 1997;349:1725\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(96)12249-2.","journal-title":"Lancet"},{"key":"3989_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/gut.47.2.251","volume":"47","author":"RJ Schlemper","year":"2000","unstructured":"Schlemper RJ. The Vienna classification of Gastrointestinal epithelial neoplasia. Gut. 2000;47:251\u20135. https:\/\/doi.org\/10.1136\/gut.47.2.251.","journal-title":"Gut"},{"key":"3989_CR32","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s11605-009-0886-7","volume":"13","author":"SJ Schoenleber","year":"2009","unstructured":"Schoenleber SJ, Schnelldorfer T, Wood CM, et al. Factors influencing lymph node recovery from the operative specimen after gastrectomy for gastric adenocarcinoma. J Gastrointest Surg. 2009;13:1233\u20137. https:\/\/doi.org\/10.1007\/s11605-009-0886-7.","journal-title":"J Gastrointest Surg"},{"key":"3989_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/his.12167","volume":"63","author":"GB Hanna","year":"2013","unstructured":"Hanna GB, Amygdalos I, Ni M, et al. Improving the standard of lymph node retrieval after gastric cancer surgery. Histopathology. 2013;63:316\u201324. https:\/\/doi.org\/10.1111\/his.12167.","journal-title":"Histopathology"},{"key":"3989_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/COC.0000000000000110","volume":"40","author":"Y-C Lee","year":"2017","unstructured":"Lee Y-C, Yang P-J, Zhong Y, et al. Lymph node Ratio-based staging system outperforms the seventh AJCC system for gastric cancer: validation analysis with National Taiwan university hospital cancer registry. Am J Clin Oncol-Canc. 2017;40:35\u201341. https:\/\/doi.org\/10.1097\/COC.0000000000000110.","journal-title":"Am J Clin Oncol-Canc"},{"key":"3989_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.suronc.2015.03.001","volume":"24","author":"OC Kutlu","year":"2015","unstructured":"Kutlu OC, Watchell M, Dissanaike S. Metastatic lymph node ratio successfully predicts prognosis in Western gastric cancer patients. Surg Oncol. 2015;24:84\u20138. https:\/\/doi.org\/10.1016\/j.suronc.2015.03.001.","journal-title":"Surg Oncol"},{"key":"3989_CR36","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12957-022-02766-0","volume":"20","author":"S Hou","year":"2022","unstructured":"Hou S, Liu F, Gao Z, et al. Pathological and oncological outcomes of pylorus-preserving versus conventional distal gastrectomy in early gastric cancer: a systematic review and meta-analysis. World J Surg Oncol. 2022;20:308. https:\/\/doi.org\/10.1186\/s12957-022-02766-0.","journal-title":"World J Surg Oncol"},{"key":"3989_CR37","first-page":"329","volume":"2009","author":"M Sasako","year":"2009","unstructured":"Sasako M, Nashimoto A, Kinoshita T. D2 lymphadenectomy alone or with Para-aortic nodal dissection for gastric cancer. N Engl J Med. 2009;2009:329\u201331.","journal-title":"N Engl J Med"},{"key":"3989_CR38","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ejso.2015.03.227","volume":"41","author":"A Biondi","year":"2015","unstructured":"Biondi A, D\u2019Ugo D, Cananzi FCM, et al. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? Eur J Surg Oncol. 2015;41:779\u201386. https:\/\/doi.org\/10.1016\/j.ejso.2015.03.227.","journal-title":"Eur J Surg Oncol"},{"key":"3989_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s10120-012-0169-y","volume":"15","author":"R Seevaratnam","year":"2012","unstructured":"Seevaratnam R, Bocicariu A, Cardoso R, et al. How many lymph nodes should be assessed in patients with gastric cancer? A systematic review. Gastric Cancer. 2012;15:70\u201388. https:\/\/doi.org\/10.1007\/s10120-012-0169-y.","journal-title":"Gastric Cancer"},{"key":"3989_CR40","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/jgh.13306","volume":"31","author":"W Okajima","year":"2016","unstructured":"Okajima W, Komatsu S, Ichikawa D, et al. Prognostic impact of the number of retrieved lymph nodes in patients with gastric cancer. J Gastroenterol Hepatol. 2016;31:1566\u201371. https:\/\/doi.org\/10.1111\/jgh.13306.","journal-title":"J Gastroenterol Hepatol"},{"key":"3989_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1245\/s10434-006-9218-2","volume":"14","author":"RE Schwarz","year":"2006","unstructured":"Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol. 2006;14:317\u201328. https:\/\/doi.org\/10.1245\/s10434-006-9218-2.","journal-title":"Ann Surg Oncol"},{"key":"3989_CR42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00384-014-1848-4","volume":"29","author":"SJ Moug","year":"2014","unstructured":"West of Scotland Colorectal Cancer Managed Clinical Network, Moug SJ, Oliphant R, et al. The lymph node ratio optimises staging in patients with node positive colon cancer with implications for adjuvant chemotherapy. Int J Colorectal Dis. 2014;29:599\u2013604. https:\/\/doi.org\/10.1007\/s00384-014-1848-4.","journal-title":"Int J Colorectal Dis"},{"key":"3989_CR43","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s11605-009-0919-2","volume":"13","author":"H Riediger","year":"2009","unstructured":"Riediger H, Keck T, Wellner U, et al. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg. 2009;13:1337\u201344. https:\/\/doi.org\/10.1007\/s11605-009-0919-2.","journal-title":"J Gastrointest Surg"},{"key":"3989_CR44","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00432-013-1525-y","volume":"139","author":"J Zhang","year":"2013","unstructured":"Zhang J, Lv L, Ye Y, et al. Comparison of metastatic lymph node ratio staging system with the 7th AJCC system for colorectal cancer. J Cancer Res Clin Oncol. 2013;139:1947\u201353. https:\/\/doi.org\/10.1007\/s00432-013-1525-y.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3989_CR45","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10549-011-1730-9","volume":"130","author":"SH Ahn","year":"2011","unstructured":"Ahn SH, Kim HJ, Lee JW, et al. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society. Breast Cancer Res Treat. 2011;130:507\u201315. https:\/\/doi.org\/10.1007\/s10549-011-1730-9.","journal-title":"Breast Cancer Res Treat"},{"key":"3989_CR46","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/SLA.0b013e31824857e2","volume":"255","author":"J Wang","year":"2012","unstructured":"Wang J, Dang P, Raut CP, et al. Comparison of a lymph node Ratio\u2013Based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg. 2012;255:478\u201385. https:\/\/doi.org\/10.1097\/SLA.0b013e31824857e2.","journal-title":"Ann Surg"},{"key":"3989_CR47","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3892\/ol.2013.1615","volume":"6","author":"W-J Zeng","year":"2013","unstructured":"Zeng W-J, Hu W-Q, Wang L-W, et al. Lymph node ratio is a better prognosticator than lymph node status for gastric cancer: A retrospective study of 138 cases. Oncol Lett. 2013;6:1693\u2013700. https:\/\/doi.org\/10.3892\/ol.2013.1615.","journal-title":"Oncol Lett"},{"key":"3989_CR48","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1093\/annonc\/mdq716","volume":"22","author":"W Wang","year":"2011","unstructured":"Wang W, Xu DZ, Li YF, et al. Tumor\u2013ratio\u2013metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection\u2014results of a single-institution study of 1343 Chinese patients. Ann Oncol. 2011;22:2049\u201356. https:\/\/doi.org\/10.1093\/annonc\/mdq716.","journal-title":"Ann Oncol"},{"key":"3989_CR49","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1245\/s10434-019-08098-w","volume":"27","author":"Z Huang","year":"2019","unstructured":"Huang Z, Chen Y, Zhang W, et al. Modified gastric cancer AJCC staging with a classification based on the ratio of regional lymph node involvement: A Population-Based cohort study. Ann Surg Oncol. 2019;27:1480\u20137. https:\/\/doi.org\/10.1245\/s10434-019-08098-w.","journal-title":"Ann Surg Oncol"},{"key":"3989_CR50","doi-asserted-by":"publisher","first-page":"e18165","DOI":"10.7717\/peerj.18165","volume":"12","author":"G Jia","year":"2024","unstructured":"Jia G, Zhou D, Tang X, et al. Prognostic value of a modified pathological staging system for gastric cancer based on the number of retrieved lymph nodes and metastatic lymph node ratio. PeerJ. 2024;12:e18165. https:\/\/doi.org\/10.7717\/peerj.18165.","journal-title":"PeerJ"},{"key":"3989_CR51","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.ejso.2015.03.225","volume":"41","author":"X-J Wu","year":"2015","unstructured":"Wu X-J, Miao R-L, Li Z-Y, et al. Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer. Eur J Surg Oncol. 2015;41:927\u201333. https:\/\/doi.org\/10.1016\/j.ejso.2015.03.225.","journal-title":"Eur J Surg Oncol"},{"key":"3989_CR52","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ejso.2012.01.012","volume":"38","author":"F Esp\u00edn","year":"2012","unstructured":"Esp\u00edn F, Bianchi A, Llorca S, et al. Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer. Eur J Surg Oncol. 2012;38:497\u2013502. https:\/\/doi.org\/10.1016\/j.ejso.2012.01.012.","journal-title":"Eur J Surg Oncol"},{"key":"3989_CR53","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1097\/SLA.0000000000001040","volume":"262","author":"G Spolverato","year":"2015","unstructured":"Spolverato G, Ejaz A, Kim Y, et al. Prognostic performance of different lymph node staging systems after curative intent resection for gastric adenocarcinoma. Ann Surg. 2015;262:991\u20138. https:\/\/doi.org\/10.1097\/SLA.0000000000001040.","journal-title":"Ann Surg"},{"key":"3989_CR54","doi-asserted-by":"publisher","first-page":"e31736","DOI":"10.1371\/journal.pone.0031736","volume":"7","author":"M Qiu","year":"2012","unstructured":"Qiu M, Qiu H, Wang Z, et al. The Tumor-Log odds of positive lymph Nodes-Metastasis staging system, a promising new staging system for gastric cancer after D2 resection in China. PLoS ONE. 2012;7:e31736. https:\/\/doi.org\/10.1371\/journal.pone.0031736.","journal-title":"PLoS ONE"},{"key":"3989_CR55","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9694","author":"H Cao","year":"2018","unstructured":"Cao H, Tang Z, Yu Z, et al. Comparison of the 8th union for international cancer control lymph node staging system for gastric cancer with two other lymph node staging systems. Oncol Lett. 2018. https:\/\/doi.org\/10.3892\/ol.2018.9694.","journal-title":"Oncol Lett"},{"key":"3989_CR56","doi-asserted-by":"publisher","first-page":"8937","DOI":"10.1245\/s10434-021-10299-1","volume":"28","author":"K Che","year":"2021","unstructured":"Che K, Wang Y, Wu N, et al. Prognostic nomograms based on three lymph node classification systems for resected gastric adenocarcinoma: A large Population-Based cohort study and external validation. Ann Surg Oncol. 2021;28:8937\u201349. https:\/\/doi.org\/10.1245\/s10434-021-10299-1.","journal-title":"Ann Surg Oncol"},{"key":"3989_CR57","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/s12885-023-10805-6","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, Wu G, Liu J, et al. Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis. BMC Cancer. 2023;23:523. https:\/\/doi.org\/10.1186\/s12885-023-10805-6.","journal-title":"BMC Cancer"},{"key":"3989_CR58","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12885-023-11023-w","volume":"23","author":"Y Tian","year":"2023","unstructured":"Tian Y, Pang Y, Yang P-G, et al. Clinical implications of micro lymph node metastasis for patients with gastric cancer. BMC Cancer. 2023;23:536. https:\/\/doi.org\/10.1186\/s12885-023-11023-w.","journal-title":"BMC Cancer"},{"key":"3989_CR59","doi-asserted-by":"publisher","first-page":"13728","DOI":"10.3748\/wjg.v20.i38.13728","volume":"20","author":"H Sonoda","year":"2014","unstructured":"Sonoda H. Clinical significance of molecular diagnosis for gastric cancer lymph node micrometastasis. World J Gastroenterol. 2014;20:13728. https:\/\/doi.org\/10.3748\/wjg.v20.i38.13728.","journal-title":"World J Gastroenterol"},{"key":"3989_CR60","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijsu.2019.12.018","volume":"74","author":"N Zhang","year":"2020","unstructured":"Zhang N, Deng J, Wang W, et al. Negative lymph node count as an independent prognostic factor in stage III patients after curative gastrectomy: A retrospective cohort study based on a multicenter database. Int J Surg. 2020;74:44\u201352. https:\/\/doi.org\/10.1016\/j.ijsu.2019.12.018.","journal-title":"Int J Surg"},{"key":"3989_CR61","doi-asserted-by":"publisher","first-page":"71197","DOI":"10.18632\/oncotarget.17430","volume":"8","author":"C Zhuo","year":"2017","unstructured":"Zhuo C, Ying M, Lin R, et al. Negative lymph node count is a significant prognostic factor in patient with stage IV gastric cancer after palliative gastrectomy. Oncotarget. 2017;8:71197\u2013205.","journal-title":"Oncotarget"},{"issue":"9","key":"3989_CR62","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3971\/j.issn.1000-8578.2022.22.0014","volume":"49","author":"JZ Li","year":"2022","unstructured":"Li JZ, Wang WJ, Yao YL, et al. Development and validation of prognostic nomogram based on negative lymph node count for patients with gastric signet ring cell carcinoma. Cancer Res Prev Treat. 2022;49(9):923\u201330. https:\/\/doi.org\/10.3971\/j.issn.1000-8578.2022.22.0014.","journal-title":"Cancer Res Prev Treat"},{"key":"3989_CR63","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.21037\/jgo-21-212","volume":"12","author":"J Jiang","year":"2021","unstructured":"Jiang J, Chen J, Zhang H, et al. Combination of the ratio between metastatic and harvested lymph nodes and negative lymph node count as a prognostic indicator in advanced gastric cancer: a retrospective cohort study. J Gastrointest Oncol. 2021;12:2022\u201334. https:\/\/doi.org\/10.21037\/jgo-21-212.","journal-title":"J Gastrointest Oncol"},{"key":"3989_CR64","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s42256-022-00559-4","volume":"4","author":"D Mincu","year":"2022","unstructured":"Mincu D, Roy S. Developing robust benchmarks for driving forward AI innovation in healthcare. Nat Mach Intell. 2022;4:916\u201321. https:\/\/doi.org\/10.1038\/s42256-022-00559-4.","journal-title":"Nat Mach Intell"},{"key":"3989_CR65","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/BF01655678","volume":"12","author":"G Heberer","year":"1988","unstructured":"Heberer G, Teichmann RK, Kr\u00e4mling H-J, et al. Results of gastric resection for carcinoma of the stomach: the European experience. World J Surg. 1988;12:374\u201380. https:\/\/doi.org\/10.1007\/BF01655678.","journal-title":"World J Surg"},{"key":"3989_CR66","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/bjs.1800820321","volume":"82","author":"M Sasako","year":"1995","unstructured":"Sasako M, McCulloch P, Kinoshita T, et al. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346\u201351. https:\/\/doi.org\/10.1002\/bjs.1800820321.","journal-title":"Br J Surg"},{"key":"3989_CR67","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/bjs.1800790221","volume":"79","author":"E Bollschweiler","year":"1992","unstructured":"Bollschweiler E, Boettcher K, Hoelscher AH, et al. Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program. Br J Surg. 1992;79:156\u201360. https:\/\/doi.org\/10.1002\/bjs.1800790221.","journal-title":"Br J Surg"},{"key":"3989_CR68","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1007\/s002680010276","volume":"24","author":"S Guadagni","year":"2000","unstructured":"Guadagni S, De Manzoni G, Catarci M, et al. Evaluation of the Maruyama computer program accuracy for preoperative Estimation of lymph node metastases from gastric cancer. World J Surg. 2000;24:1550\u20138. https:\/\/doi.org\/10.1007\/s002680010276.","journal-title":"World J Surg"},{"key":"3989_CR69","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/BF02573066","volume":"9","author":"SA Hundahl","year":"2002","unstructured":"Hundahl SA, Macdonald JS, Benedetti J. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol. 2002;9:278\u201386.","journal-title":"Ann Surg Oncol"},{"key":"3989_CR70","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10120-007-0426-7","volume":"10","author":"SA Hundahl","year":"2007","unstructured":"Hundahl SA, Peeters KCMJ, Kranenbarg EK, et al. Improved regional control and survival with low Maruyama index surgery in gastric cancer: autopsy findings from the Dutch D1-D2 trial. Gastric Cancer. 2007;10:84\u20136. https:\/\/doi.org\/10.1007\/s10120-007-0426-7.","journal-title":"Gastric Cancer"},{"key":"3989_CR71","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10120-012-0170-5","volume":"16","author":"D T\u00f3th","year":"2012","unstructured":"T\u00f3th D, T\u00f6r\u00f6k M, Kincses Z, et al. Prospective, comparative study for the evaluation of lymph node involvement in gastric cancer: Maruyama computer program versus Sentinel lymph node biopsy. Gastric Cancer. 2012;16:201\u20137. https:\/\/doi.org\/10.1007\/s10120-012-0170-5.","journal-title":"Gastric Cancer"},{"key":"3989_CR72","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.annonc.2020.04.003","volume":"31","author":"D Dong","year":"2020","unstructured":"Dong D, Fang M-J, Tang L, et al. Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study. Ann Oncol. 2020;31:912\u201320. https:\/\/doi.org\/10.1016\/j.annonc.2020.04.003.","journal-title":"Ann Oncol"},{"key":"3989_CR73","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.radonc.2021.11.003","volume":"165","author":"Z Sun","year":"2021","unstructured":"Sun Z, Jiang Y, Chen C, et al. Radiomics signature based on computed tomography images for the preoperative prediction of lymph node metastasis at individual stations in gastric cancer: A multicenter study. Radiother Oncol. 2021;165:179\u201390. https:\/\/doi.org\/10.1016\/j.radonc.2021.11.003.","journal-title":"Radiother Oncol"},{"key":"3989_CR74","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ejrad.2016.03.003","volume":"85","author":"Y Kawanaka","year":"2016","unstructured":"Kawanaka Y, Kitajima K, Fukushima K, et al. Added value of pretreatment 18F-FDG PET\/CT for staging of advanced gastric cancer: comparison with contrast-enhanced MDCT. Eur J Radiol. 2016;85:989\u201395. https:\/\/doi.org\/10.1016\/j.ejrad.2016.03.003.","journal-title":"Eur J Radiol"},{"key":"3989_CR75","first-page":"1582","volume":"46","author":"M Yun","year":"2005","unstructured":"Yun M, Lim JS, Noh SH, et al. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT. J Nucl Med. 2005;46:1582\u20138.","journal-title":"J Nucl Med"},{"key":"3989_CR76","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s10120-008-0492-5","volume":"12","author":"RM Kwee","year":"2009","unstructured":"Kwee RM, Kwee TC. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer. 2009;12:6\u201322. https:\/\/doi.org\/10.1007\/s10120-008-0492-5.","journal-title":"Gastric Cancer"},{"key":"3989_CR77","doi-asserted-by":"publisher","first-page":"723345","DOI":"10.3389\/fonc.2021.723345","volume":"11","author":"Q Liu","year":"2021","unstructured":"Liu Q, Li J, Xin B, et al. 18F-FDG PET\/CT radiomics for preoperative prediction of lymph node metastases and nodal staging in gastric cancer. Front Oncol. 2021;11:723345. https:\/\/doi.org\/10.3389\/fonc.2021.723345.","journal-title":"Front Oncol"},{"key":"3989_CR78","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1007\/s00261-023-04037-2","volume":"48","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Li L, Han K, et al. A radio-pathologic integrated model for prediction of lymph node metastasis stage in patients with gastric cancer. Abdom Radiol (NY). 2023;48:3332\u201342. https:\/\/doi.org\/10.1007\/s00261-023-04037-2.","journal-title":"Abdom Radiol (NY)"},{"key":"3989_CR79","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2471\/BLT.19.237487","volume":"98","author":"I Habli","year":"2020","unstructured":"Habli I, Lawton T, Porter Z. Artificial intelligence in health care: accountability and safety. Bull World Health Organ. 2020;98:251\u20136. https:\/\/doi.org\/10.2471\/BLT.19.237487.","journal-title":"Bull World Health Organ"},{"key":"3989_CR80","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s10120-015-0468-1","volume":"19","author":"F Giganti","year":"2015","unstructured":"Giganti F, Orsenigo E, Arcidiacono PG, et al. Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging? Prospective comparison with EUS and multidetector computed tomography. Gastric Cancer. 2015;19:216\u201325. https:\/\/doi.org\/10.1007\/s10120-015-0468-1.","journal-title":"Gastric Cancer"},{"key":"3989_CR81","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/gut.32.5.479","volume":"32","author":"K Akahoshi","year":"1991","unstructured":"Akahoshi K, Misawa T, Fujishima H, et al. Preoperative evaluation of gastric cancer by endoscopic ultrasound. Gut. 1991;32:479\u201382. https:\/\/doi.org\/10.1136\/gut.32.5.479.","journal-title":"Gut"},{"key":"3989_CR82","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/BF02307062","volume":"2","author":"J-P Kim","year":"1995","unstructured":"Kim J-P, Hur YS, Yang H-K. Lymph node metastasis as a significant prognostic factor in early gastric cancer: analysis of 1,136 early gastric cancers. Ann Surg Oncol. 1995;2:308\u201313. https:\/\/doi.org\/10.1007\/BF02307062.","journal-title":"Ann Surg Oncol"},{"key":"3989_CR83","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/SLA.0b013e31811f3fb7","volume":"246","author":"JY An","year":"2007","unstructured":"An JY, Baik YH, Choi MG, et al. Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience. Ann Surg. 2007;246:749\u201353. https:\/\/doi.org\/10.1097\/SLA.0b013e31811f3fb7.","journal-title":"Ann Surg"},{"key":"3989_CR84","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1097\/SLA.0000000000005332","volume":"277","author":"EL Vos","year":"2023","unstructured":"Vos EL, Nakauchi M, G\u00f6nen M, et al. Risk of lymph node metastasis in T1b gastric cancer: an international comprehensive analysis from the global gastric group (G3) alliance. Ann Surg. 2023;277:e339\u201345. https:\/\/doi.org\/10.1097\/SLA.0000000000005332.","journal-title":"Ann Surg"},{"key":"3989_CR85","doi-asserted-by":"publisher","first-page":"101634","DOI":"10.1016\/j.clinre.2021.101634","volume":"45","author":"P Jin","year":"2021","unstructured":"Jin P, Ji X, Ma S, et al. Adjuvant chemotherapy indications for stage I gastric cancer patients with negative lymph node. Clin Res Hepatol Gas. 2021;45:101634. https:\/\/doi.org\/10.1016\/j.clinre.2021.101634.","journal-title":"Clin Res Hepatol Gas"},{"key":"3989_CR86","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.amjsurg.2005.05.042","volume":"190","author":"N Abe","year":"2005","unstructured":"Abe N, Mori T, Takeuchi H, et al. Laparoscopic lymph node dissection after endoscopic submucosal dissection: a novel and minimally invasive approach to treating early-stage gastric cancer. Am J Surg. 2005;190:496\u2013503. https:\/\/doi.org\/10.1016\/j.amjsurg.2005.05.042.","journal-title":"Am J Surg"},{"key":"3989_CR87","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1007\/s00464-024-10761-7","volume":"38","author":"AY Lee","year":"2024","unstructured":"Lee AY, Kim YJ, Cho S, et al. Endoscopic resection and laparoscopic lymph node dissection for early gastric cancer beyond conventional endoscopic treatment indications: a 10-year outcome study. Surg Endosc. 2024;38:2533\u201341. https:\/\/doi.org\/10.1007\/s00464-024-10761-7.","journal-title":"Surg Endosc"},{"key":"3989_CR88","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1200\/JCO.2013.50.3789","volume":"31","author":"Y Kitagawa","year":"2013","unstructured":"Kitagawa Y, Takeuchi H, Takagi Y, et al. Sentinel node mapping for gastric cancer: A prospective multicenter trial in Japan. J Clin Oncol. 2013;31:3704\u201310. https:\/\/doi.org\/10.1200\/JCO.2013.50.3789.","journal-title":"J Clin Oncol"},{"key":"3989_CR89","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1136\/gut.2008.165381","volume":"58","author":"H Isomoto","year":"2008","unstructured":"Isomoto H, Shikuwa S, Yamaguchi N, et al. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut. 2008;58:331\u20136. https:\/\/doi.org\/10.1136\/gut.2008.165381.","journal-title":"Gut"},{"key":"3989_CR90","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s10120-017-0704-y","volume":"21","author":"N Hasuike","year":"2017","unstructured":"Gastrointestinal Endoscopy Group of Japan Clinical Oncology Group (JCOG-GIESG), Hasuike N, Ono H, et al. A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan clinical oncology group study (JCOG0607). Gastric Cancer. 2017;21:114\u201323. https:\/\/doi.org\/10.1007\/s10120-017-0704-y.","journal-title":"Gastric Cancer"},{"key":"3989_CR91","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1055\/s-2006-944775","volume":"38","author":"M Fujishiro","year":"2006","unstructured":"Fujishiro M, Yahagi N, Kakushima N, et al. Successful nonsurgical management of perforation complicating endoscopic submucosal dissection of Gastrointestinal epithelial neoplasms. Endoscopy. 2006;38:1001\u20136. https:\/\/doi.org\/10.1055\/s-2006-944775.","journal-title":"Endoscopy"},{"key":"3989_CR92","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"Y-J Bang","year":"2012","unstructured":"Bang Y-J, Kim Y-W, Yang H-K, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315\u201321. https:\/\/doi.org\/10.1016\/S0140-6736(11)61873-4.","journal-title":"Lancet"},{"key":"3989_CR93","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00280-010-1296-y","volume":"67","author":"IH Park","year":"2010","unstructured":"Park IH, Kim SY, Kim Y-W, et al. Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement. Cancer Chemother Pharmacol. 2010;67:127\u201336. https:\/\/doi.org\/10.1007\/s00280-010-1296-y.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3989_CR94","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/bjs.9484","volume":"101","author":"A Tsuburaya","year":"2014","unstructured":"Tsuburaya A, Mizusawa J, Tanaka Y, et al. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg. 2014;101:653\u201360. https:\/\/doi.org\/10.1002\/bjs.9484.","journal-title":"Br J Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03989-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03989-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03989-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:45:12Z","timestamp":1758739512000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03989-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3989"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03989-7","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"11 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The formal ethical review was waived by our institutional review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"338"}}